• Aucun résultat trouvé

Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.

N/A
N/A
Protected

Academic year: 2021

Partager "Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients."

Copied!
2
0
0

Texte intégral

(1)

HAL Id: inserm-00325812

https://www.hal.inserm.fr/inserm-00325812

Submitted on 30 Sep 2008

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of sci-entific research documents, whether they are pub-lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Comparison of the antiviral activity of adefovir and

tenofovir on hepatitis B virus in HIV-HBV-coinfected

patients.

Karine Lacombe, Joël Gozlan, Anders Boyd, Pierre-Yves Boelle, Philippe

Bonnard, Jean-Michel Molina, Patrick Miailhes, Caroline Lascoux-Combe,

Lawrence Serfaty, Fabien Zoulim, et al.

To cite this version:

Karine Lacombe, Joël Gozlan, Anders Boyd, Pierre-Yves Boelle, Philippe Bonnard, et al.. Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.. Antiviral Therapy, International Medical Press, 2008, 13 (5), pp.705-13. �inserm-00325812�

(2)

Figure 2: Modelling of HBV-DNA dynamics between inclusion and month 6 according to treatment. 0 1 2 3 4 5 6 0 2 4 6 8 1 0 1 2 Time (months) ADV TDF H B V D N A ( lo g 1 0 c o p ie s /m l ) p = 0.0036

Figure

Figure 2: Modelling of HBV-DNA dynamics between inclusion and month 6  according to treatment

Références

Documents relatifs

Ces chocs organisationnels ont accru l'intensité du travail et se sont sou- vent accompagnés d'une perte d'autonomie : non seulement ils ont plus de tâches à accomplir, mais ils

Au quatrième trimestre 2018, en France métropolitaine, 68,1 % des personnes inscrites à Pôle emploi en catégories A, B, C, D, E ou dispensées de recherche d'emploi sont indemnisables

drug-resistant mutants than lamivudine and entecavir; adefovir had slightly higher resistance 152. factors for these mutants but its in vivo pharmacological characteristics

a Department of Chemistry, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran b Institut Européen des Membranes, Université de Montpellier, 34095

Migration analysis showed a gene flow from zone 3 (rural) to zone 2 (suburban) and a greater gene flow from the middle part of Madagascar to the north than to the south.. It

sous-variété fermée de AI ayant toutes ses feuilles partout dem,es. 2- J\1éthode générale de construction des feuilletages de Lie.. Ce type de construction peut

A given program can have many candidate execution witnesses, with different control-flow paths, different values read from memory, different reads- from relations, and different

Binary packages contain files that can be installed directly from the package file; source packages contain source code that can be used to create binary packages—it is possible